In addition, many studies have shown that SOX1 can be used as a biomarker for a variety of tumors, such as cervical cancer, colon cancer, glioma, liver cancer, ovarian cancer, and small cell lung cancer [28–33]. Here, SOX1 is linked to ovarian carcinoma.